NCT00544960 2010-08-27A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung CancerAscenta TherapeuticsPhase 2 Completed106 enrolled
NCT00397293 2010-08-24Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung CancerAscenta TherapeuticsPhase 1/2 Completed36 enrolled